The Trump administration on Tuesday announced a new study to test whether personalized masks could be a way to keep people who have Alzheimer’s from developing the disease.
The National Institutes of Health has been studying how to design personalized masks for people living with Alzheimers, and is currently developing a mask for older people.
The goal is to make them so that they’re easier to wear, less cumbersome to wear and less distracting than traditional masks.
The NIH study was funded by the U.S. Department of Veterans Affairs.
The first phase of the study, which will last at least two years, will look at whether the masks could reduce the frequency of patients presenting to the Mayo Clinic’s Advanced Care Clinic in Rochester, Minnesota, and the Mayo Hospital in Rochester.
The masks could also be used to help patients who have dementia and who may need extra care.
In one of the Phase 2 studies, researchers will measure the effect of the masks on patients who are unable to wear their own.
Researchers will also look at the masks effectiveness on patients with other diseases and conditions, including dementia.
If all goes well, the mask could be available for a limited time at a discounted price.
Phase 2 is expected to be completed by the end of 2018.
The researchers will also be able to measure the masks effect on the number of visits to the hospital, as well as the patients who wear the masks.
While the masks will not be marketed in the U, the FDA will allow manufacturers to offer them to patients, and will be able access data from those trials.
In the first phase, patients will be asked to wear masks for about two weeks, during which time they will be monitored for signs of cognitive decline.
Researchers plan to follow up with patients after the masks are worn to see if there is a change in symptoms.
This is the second study to study whether the devices could reduce dementia risk.
The Mayo Clinic in New York recently tested the masks for the disease in patients who had Alzheimer’s and found that the masks did not decrease the risk of developing dementia.